Articles

Restless Legs Syndrome Market - Research Report, 2023

by PSMR Industry Web Marketing

Restless legs syndrome increases at night when the patient is at rest. RLS are common in both, male and female; however the disease has its highest impact on woman who are elderly or in some cases woman with the age 35 to 50 years. Some of the most common symptoms of the restless legs syndrome are continue itching and pain in the legs, and unusual sleep pattern. The restless legs syndrome affects the quality of life of the person suffering from the disease.

To know more about “Restless Legs Syndrome Market” visit: https://www.psmarketresearch.com/market-analysis/restless-legs-syndrome-market

The exact treatment of this disease is not present till now. However the available drug in the market helps in the indicative treatment of the disease. Some of the drug in the restless legs syndrome market such as sulfonamide by safinamide by Newron Pharmaceuticals reduces the symptoms by novel action such as potent, reversible and selective inhibition of MAO-B, without disturbing the MAO-A and dopamine uptake. This enhances the glutamate release and dopaminergic function of the patients; it also reduces the dopamine degradation. One other drug: SER-214 manufacture by Serina is used widely in the restless legs syndrome treatment; it uses a water-soluble polymer poly (2-alkyloxazoline)-based drug delivery technology this drug can be combined with the polymer and transported to the patients.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/restless-legs-syndrome-market/report-sample

Some of the major players operating in the global restless legs syndrome market include, GlaxoSmithKline plc., Ligand Pharmaceuticals Incorporated, axxonis Pharma AG, Kyowa Hakko Kirin Co., Jazz Pharmaceuticals, Inc., Omeros Corporation, Manhattan Pharmaceuticals, Boehringer Ingelheim GmbH, UCB SA.

Sponsor Ads


About PSMR Industry Advanced   Web Marketing

44 connections, 0 recommendations, 155 honor points.
Joined APSense since, March 9th, 2016, From New York, United States.

Created on Sep 14th 2017 17:51. Viewed 297 times.

Comments

No comment, be the first to comment.
Please sign in before you comment.